Venetoclax in Combination With Cladribine and Cytarabine Alternating With Azacitidine Plus Venetoclax for the Treatment of Newly Diagnosed Monocytic AML and Active Signaling Mutated AML
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
City of Hope Medical Center
Fred Hutchinson Cancer Center
Thomas Jefferson University
Fred Hutchinson Cancer Center
University of Washington
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Gruppo Italiano Malattie EMatologiche dell'Adulto
Roswell Park Cancer Institute
Rush University Medical Center
Rutgers, The State University of New Jersey
Rutgers, The State University of New Jersey
Alliance for Clinical Trials in Oncology
H. Lee Moffitt Cancer Center and Research Institute
University of Chicago
Northwestern University
Stanford University
Wake Forest University Health Sciences
University of Southern California
Stanford University
Fred Hutchinson Cancer Center
Wake Forest University Health Sciences
University of Alberta
Fred Hutchinson Cancer Center
City of Hope Medical Center
Stichting Hemato-Oncologie voor Volwassenen Nederland
Alliance for Clinical Trials in Oncology
Roswell Park Cancer Institute
Barbara Ann Karmanos Cancer Institute
Case Comprehensive Cancer Center
University Health Network, Toronto
Roswell Park Cancer Institute
University of Rochester
Memorial Sloan Kettering Cancer Center
The Cleveland Clinic
H. Lee Moffitt Cancer Center and Research Institute
Barbara Ann Karmanos Cancer Institute
Roswell Park Cancer Institute
Roswell Park Cancer Institute